Trident Texofab Ltd. · BSE:TTFL
Trident Texofab — Q3 FY2020 Earnings Presentation
14 slides from Trident Texofab's earnings presentation, February 2020
Slide 1: Cover letter to BSE: Earning Presentation Q3FY20
CIN No.: L17120GJ2008PLCO54976 S TRIDENT 1 TEXOFAB LIMITED Date: 06th February, 2020 To, The Manager, Listing Department, BSE Limited, Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai 400 001 BSE Scrip Code: 540726 Dear Sir/Madam, Sub: Earning Presentation- Q3FY20 Pursuant to Regulation 30 of SEBI (Li
Slide 2: Trident Texofab Limited Q3FY20 Earnings Presentation
TRIDENT TEXOFAB LIMITED Q3FY20 Earnings Presentation BSE: TTFL Bloomberg: TTFLTD:IN February 2020
Slide 3: Company Overview
COMPANY OVERVIEW • Incorporated in 2008, Trident Texofab Limited is a composite textile manufacturing and trading company dealing in various finished and semi- finished products such as home furnishing, garments, suiting and shirting. • TTFL has recently started manufacturing polyster- blend fabrics
Slide 4: Company Snapshot
First Generation Promoters 100 Team Strength 500 Lakh meters Composite Annual Manufacturing Capacity Manufacturing Unit BSE SME Listed Shift from Pure trading to composite manufacturing unit Wide portfolio of finished and semi-finished products COMPANY SNAPSHOT Retail Clientele: TCNS, Libas
Slide 5: Business Division
BUSINESS DIVISION Manufacturing Trading • Commenced in 2018, • Majority business contributor contributed 24.90% of since inception. Contributed revenue in FY2019. 75.10% of sale in FY2019. • To drive incremental growth • Will maintain similar level of at TTFL in the years to operations as witnessed
Slide 6: Product Portfolio: Manufacturing
PRODUCT PORTFOLIO MANUFACTURING Finished Products • Kurtis • Tunics • Nighty • Suiting • Gowns Semi-Finished Products • Grey Fabrics • Job Work for Digital Printing • Value Added Products: Embroidery,etc.
Slide 7: Product Portfolio: Trading
PRODUCT PORTFOLIO TRADING Finished Products • Curtains & Shower Curtains • Cushion Covers • Quilt Sheets • Bed Sheets • All Overs
Slide 8: Financial Summary: Profit & Loss (Quarterly)
FINANCIAL SUMMARY Profit & Loss Summary (Quarterly) (In Lakhs) PARTICULARS Q3FY20 Q2FY20 Q3FY19 Y-o-Y % (Unaudited) (Unaudited) (Unaudited) (change) Revenue from operations 1992.15 2237.86 1674.07 19.00% Total Income 1999.34 2245.36 1682.59 18.83% Total Operating Expenses 1847.38 2111.98 1614.26 14.
Slide 9: Financial Summary: Profit & Loss
FINANCIAL SUMMARY Profit & Loss Summary (In Lakhs) PARTICULARS FY19 FY18 FY17 FY16 FY15 Revenue from operations 8689.74 8546.24 7594.76 6597.91 6255.87 Total Income 8736.54 8594.15 7619.19 6603.29 6265.38 Total Operating Expenses 8450.88 8400.93 7480.00 6499.34 6137.96 EBIDTA (Excluding Ol) 238.86 1
Slide 10: Financial Summary: Balance Sheet
FINANCIAL SUMMARY Balance Sheet Summary (In Lakhs) PARTICULARS FY19 FY18 FY17 FY16 FY15 Shareholders Fund 1099.54 826.36 380.39 346.28 343.41 Non-Current Liabilities 926.19 419.11 370.53 52.35 119.59 Current Liabilities 2882.75 3248.20 1698.63 3400.06 2378.84 Total 4908.47 4493.67 2449.55 3798.69 28
Slide 11: Financial Ratios
FINANCIAL RATIOS Gross Profit % EBIDTA % (Excluding O.I. & Exceptional Items) 15.00% 8.0% 14.30% EBIDTA % (Excluding O.I. & Exceptional Items) 7.3% 6.0% 11.50% 10.00% 9.80% 5.3% Gross Profit % 4.0% 3.6% 5.00% 2.0% 0.00% 0.0% Q3FY20 Q2FY20 Q3FY19 Q3FY20 Q2FY20 Q3FY19 Debt to Equity Interest Coverage
Slide 12: Management Commentary
MANAGEMENT COMMENTARY Result Discussion • The company has recorded a commendable • The company reported a PAT of 23.18 Lakhs in growth in revenue from operations despite Q3FY20, a decrease of 6.53%, as compared to adverse marco-economic conditions and 24.80 Lakhs in Q3FY19. challenging business envi
Slide 13: Contact Us
Ms. Bhumika Punjabi (Corporate Governance Manager) Trident Texofab Limited bhumika@tridenttexofab.com 0261 – 2451274/2451284 CONTACT US
Slide 14: Disclaimer
No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the date of this